Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Genomic Medicine Sweden

Reference number
Coordinator Karolinska Institutet - Inst. för molekylärmedicin och kirurgi
Funding from Vinnova SEK 4 997 079
Project duration June 2018 - December 2018
Status Completed

Purpose and goal

Genomic Medicine Sweden (GMS) aims to strengthen precision medicine across the country. This will be accomplished through the implementation of large-scale sequencing techniques in Swedish healthcare, resulting in improved healthcare, strengthened Swedish research in the area, and provide a foundation for innovation and collaboration with industry. With a patient-centered view, initial efforts will focus on rare inherited diseases, cancer, pharmacogenomics and infectious diseases, and be extended to other complex diseases (e.g. noncommunicable diseases).

Expected results and effects

GMS has established an organizational model at the national and regional level, which is currently being implemented. The startup seed grant was focused on the disease groups for cancer (hematology and solid tumors), where a common national strategy was developed to implement the new sequencing technologies and the scope of national pilot projects was defined. Efforts on developing a national informatics platform has begun based on the inputs from the diagnostic platform special needs and ethical and legal aspects of operable frameworks.

Planned approach and implementation

The aim of the project was to develop an organizational foundation for GMS to enter the next step of implementing precision medicine into Swedish healthcare. This has been achieved and is now being implemented. Specific goals and results: 1) Validate and approve an organizational model and activity plan on a national level, 2) Validate and approve GMS plans within existing professional Academic and Healthcare, 3) Develop common strategic goals with well-defined milestones, 4) Prepare scientific supporting materials, 5) Investigate key challenges within the ELSI work package.

External links

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 8 January 2019

Reference number 2018-02506

Page statistics